Published in Int J Methods Psychiatr Res on November 04, 2011
Sequenced Treatment Alternatives to Relieve Depression (STAR*D) | NCT00021528
Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. J Psychiatr Res (2014) 1.09
Pharmacologic treatment of dimensional anxious depression: a review. Prim Care Companion CNS Disord (2014) 0.90
A single infusion of ketamine improves depression scores in patients with anxious bipolar depression. Bipolar Disord (2014) 0.81
Ziprasidone augmentation for anxious depression. Int Clin Psychopharmacol (2016) 0.76
Instability of default mode network connectivity in major depression: a two-sample confirmation study. Transl Psychiatry (2017) 0.75
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA (2003) 34.83
The assessment of anxiety states by rating. Br J Med Psychol (1959) 24.58
Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol (1967) 22.39
Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet (2007) 15.96
Evidence-based health policy--lessons from the Global Burden of Disease Study. Science (1996) 13.50
The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med (1996) 7.70
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials (2004) 6.64
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med (2006) 6.00
The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry (2004) 5.70
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am (2003) 5.05
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry (2008) 4.98
The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res (1986) 4.16
Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl (1996) 3.99
An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report. Biol Psychiatry (2005) 3.03
A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Arch Gen Psychiatry (2001) 2.53
Assessing the burden of disease in the United States using disability-adjusted life years. Am J Prev Med (2005) 2.40
Understanding sensitivity and specificity with the right side of the brain. BMJ (2003) 2.27
The differentiation of anxiety and depression by rating scales. Acta Psychiatr Scand (1988) 1.95
Systematic use of patient-rated depression severity monitoring: is it helpful and feasible in clinical psychiatry? Psychiatr Serv (2008) 1.73
Summed-score linking using item response theory: application to depression measurement. Psychol Assess (2000) 1.68
Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med (2004) 1.64
Psychiatrists in the UK do not use outcomes measures. National survey. Br J Psychiatry (2002) 1.51
Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. J Affect Disord (2005) 1.49
On the psychometric validity of the domains of the PDSQ: an illustration of the bi-factor item response theory model. J Psychiatr Res (2008) 1.47
The Hamilton depression scale. Evaluation of objectivity using logistic models. Acta Psychiatr Scand (1981) 1.43
The reliability and validity of a screening Questionnaire for 13 DSM-IV Axis I disorders (the Psychiatric Diagnostic Screening Questionnaire) in psychiatric outpatients. J Clin Psychiatry (1999) 1.41
STAR*D: revising conventional wisdom. CNS Drugs (2009) 1.41
Major depressive subtypes and treatment response. Biol Psychiatry (1997) 1.28
Measurement-based care for refractory depression: a clinical decision support model for clinical research and practice. Drug Alcohol Depend (2007) 1.19
Psychopathological dimensions of depression: a factor study of the 17-item Hamilton depression rating scale in unipolar depressed outpatients. J Affect Disord (2002) 1.14
Rating scales for affective disorders: their validity and consistency. Acta Psychiatr Scand Suppl (1981) 1.13
Clinical vs. self-report versions of the quick inventory of depressive symptomatology in a public sector sample. J Psychiatr Res (2006) 1.11
Toward a generalizable model of symptoms in major depressive disorder. Biol Psychiatry (1998) 1.10
Why don't psychiatrists use scales to measure outcome when treating depressed patients? J Clin Psychiatry (2008) 0.97
Concordance between clinical assessments and patients' self-report in depression. Arch Gen Psychiatry (1972) 0.95
The Illness Attitude Scales. A clinimetric index for assessing hypochondriacal fears and beliefs. Psychother Psychosom (2008) 0.90
Anxious depression. J Clin Psychiatry (1998) 0.90
Modern psychometrics in clinimetrics: impact on clinical trials of antidepressants. Psychother Psychosom (2004) 0.89
Item Response Analysis of the Inventory of Depressive Symptomatology. Neuropsychiatr Dis Treat (2006) 0.87
Factorial structure of the 17-item Hamilton Depression Rating Scale. Acta Psychiatr Scand (1995) 0.87
Screening for anxiety disorders in depressed patients. J Psychiatr Res (2006) 0.83
Fifty years with the Hamilton scales for anxiety and depression. A tribute to Max Hamilton. Psychother Psychosom (2009) 0.82
A clinically useful anxiety outcome scale. J Clin Psychiatry (2010) 0.81
A psychometric evaluation of the clinician-rated Quick Inventory of Depressive Symptomatology (QIDS-C16) in patients with bipolar disorder. Int J Methods Psychiatr Res (2009) 0.79
Rating depression in normals and depressives: observer versus self-rating scales. J Affect Disord (1986) 0.79
The additional value of clinimetrics needs to be established rather than assumed. Psychother Psychosom (2004) 0.79
Screening for mental health problems among patients with substance use disorders: preliminary findings on the validation of a self-assessment instrument. Can J Psychiatry (2007) 0.77
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA (2003) 34.83
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry (2006) 14.15
The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry (2003) 13.60
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry (2006) 12.41
Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. JAMA (2006) 9.55
Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med (2007) 8.07
Surgery versus nonsurgical treatment of lumbar spinal stenosis: a randomized trial. Ann Intern Med (2015) 6.66
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials (2004) 6.64
A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34
Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA (2006) 6.26
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med (2006) 6.00
Medication augmentation after the failure of SSRIs for depression. N Engl J Med (2006) 5.16
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am (2003) 5.05
Exercise treatment for depression: efficacy and dose response. Am J Prev Med (2005) 4.99
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry (2008) 4.98
Comparison of hypothermia and normothermia after severe traumatic brain injury in children (Cool Kids): a phase 3, randomised controlled trial. Lancet Neurol (2013) 4.20
Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci U S A (2002) 4.00
Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry (2009) 3.96
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry (2006) 3.90
Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology (2006) 3.80
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry (2012) 3.73
Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry (2010) 3.72
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry (2006) 3.66
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol (2008) 3.65
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry (2003) 3.60
Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry (2004) 3.43
Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry (2008) 3.40
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry (2007) 3.38
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry (2011) 3.34
Estimating Individualized Treatment Rules Using Outcome Weighted Learning. J Am Stat Assoc (2012) 3.13
An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report. Biol Psychiatry (2005) 3.03
Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task. J Psychiatr Res (2008) 3.01
Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry (2006) 2.93
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. Am J Psychiatry (2006) 2.90
Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am J Psychiatry (2007) 2.87
A matched cohort study of superomedial pedicle vertical scar breast reduction (100 breasts) and traditional inferior pedicle Wise-pattern reduction (100 breasts): an outcomes study over 3 years. Plast Reconstr Surg (2013) 2.85
Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry (2006) 2.85
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry (2007) 2.84
The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2006) 2.68
Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study. Am J Psychiatry (2011) 2.58
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci U S A (2003) 2.56